Advanced Healthcare Materials,
Journal Year:
2020,
Volume and Issue:
10(1)
Published: Nov. 1, 2020
Abstract
Cancer
immunotherapy
is
a
cutting‐edge
strategy
that
eliminates
cancer
cells
by
amplifying
the
host's
immune
system.
However,
low
response
rate
and
risks
of
inducing
systemic
toxicity
have
raised
uncertainty
in
treatment.
Magnetic
nanoparticles
(MNPs)
as
versatile
theranostic
tool
can
be
used
to
target
delivery
multiple
immunotherapeutics
monitor
cell/tissue
responses.
These
capabilities
enable
real‐time
characterization
factors
contribute
immunoactivity
so
future
treatments
optimized.
The
magnetic
properties
MNPs
further
allow
implementation
navigation
hyperthermia
for
boosting
efficacy
immunotherapy.
multimodal
approach
opens
an
avenue
induce
robust
responses,
minimize
safety
issues,
activities
simultaneously.
Thus,
object
this
review
provide
overview
burgeoning
fields
highlight
novel
technologies
next‐generation
correlates
with
latest
treatment
strategies
explore
crosstalk
between
nanomaterials
This
comprehensive
MNP‐derived
covers
obstacles
opportunities
development
clinical
translation.
Small,
Journal Year:
2020,
Volume and Issue:
16(38)
Published: Aug. 18, 2020
Abstract
The
progress
of
antitumor
immunotherapy
is
usually
limited
by
tumor‐associated
macrophages
(TAMs)
that
account
for
the
highest
proportion
immunosuppressive
cells
in
tumor
microenvironment,
and
TAMs
can
also
be
reversed
modulating
M2‐like
phenotype.
Herein,
a
biomimetic
polymer
magnetic
nanocarrier
developed
with
selectively
targeting
polarizing
potentiating
breast
cancer.
This
PLGA‐ION‐R837
@
M
(PIR
M)
achieved,
first,
fabrication
nanoparticles
(NPs)
encapsulating
Fe
3
O
4
NPs
Toll‐like
receptor
7
(TLR7)
agonist
imiquimod
(R837)
and,
second,
coating
lipopolysaccharide
(LPS)‐
treated
macrophage
membranes
on
surface
TAMs.
intracellular
uptake
PIR
greatly
polarize
from
M2
to
M1
phenotype
synergy
R837.
relevant
mechanism
polarization
deeply
studied
through
analyzing
mRNA
expression
signaling
pathways.
Different
previous
reports,
ascribed
fact
mainly
activate
IRF5
pathway
via
iron
ions
instead
reactive
oxygen
species‐induced
NF‐κB
pathway.
anticancer
effect
effectively
enhanced
combination
ACS Nano,
Journal Year:
2019,
Volume and Issue:
13(11), P. 12553 - 12566
Published: Nov. 5, 2019
Efficient
cancer
vaccines
not
only
require
the
co-delivery
of
potent
antigens
and
highly
immunostimulatory
adjuvants
to
initiate
robust
tumor-specific
host
immune
response
but
also
solve
spatiotemporal
consistency
immunity
tumor
microenvironment
(TME)
immunomodulation.
Here,
we
designed
a
biomaterials-based
strategy
for
converting
tumor-derived
antigenic
microparticles
(T-MPs)
into
vaccine
meet
this
conundrum
demonstrated
its
therapeutic
potential
in
multiple
murine
models.
The
internal
cavity
T-MPs
was
employed
store
nano-Fe3O4
(Fe3O4/T-MPs),
then
dense
adjuvant
CpG-loaded
liposome
arrays
(CpG/Lipo)
were
tethered
on
surface
Fe3O4/T-MP
through
mild
engineering
get
(Fe3O4/T-MPs-CpG/Lipo),
demonstrating
that
Fe3O4/T-MPs
CpG/Lipo
antigen
presenting
cells
(APCs)
could
elicit
strong
antigen-specific
response.
Meanwhile,
distributed
TME
reverse
infiltrated
tumor-associated
macrophages
tumor-suppressive
M1
phenotype
by
nano-Fe3O4,
amazingly
induce
abundant
infiltration
cytotoxic
T
lymphocytes,
transform
"cold"
"hot"
tumor.
Furthermore,
amplified
antitumor
realized
combination
an
Fe3O4/T-MPs-CpG/Lipo
checkpoint
PD-L1
blockade,
specifically
inhibiting
∼83%
progression
B16F10-bearing
mice
extending
median
survival
time
3
months.
Overall,
study
synergistically
modulates
immunosuppressive
network
manner,
which
suggests
general
cell-engineering
tailored
personalized
from
autologous
cell
materials
each
individual
patient.
Advanced Materials,
Journal Year:
2021,
Volume and Issue:
33(50)
Published: June 13, 2021
Abstract
Numerous
clinical
trials
for
cancer
precision
medicine
research
are
limited
due
to
the
drug
resistance,
side
effects,
and
low
efficacy.
Unsatisfactory
outcomes
often
caused
by
complex
physiologic
barriers
abnormal
immune
events
in
tumors,
such
as
tumor
target
alterations
immunosuppression.
Cell/bacteria‐derived
materials
with
unique
bioactive
properties
have
emerged
attractive
tools
personalized
therapy
cancer.
Naturally
derived
materials,
cell
bacterial
therapeutic
agents
native
tropism
or
good
biocompatibility,
can
precisely
tumors
effectively
modulate
microenvironments
inhibit
tumors.
Here,
recent
advances
development
of
cell/bacteria‐based
modulation
summarized.
Cell/bacterial
constituents,
including
membranes,
vesicles,
other
active
substances
inherited
their
targeting
antitumor
capabilities.
Strategies
engineering
living
cell/bacteria
overcome
biological
immunosuppression
promote
efficacy
also
Moreover,
past
ongoing
involving
promising
micro/nano‐biorobotics
further
discussed,
which
may
become
another
powerful
tool
treatment
near
future.
Advanced Healthcare Materials,
Journal Year:
2020,
Volume and Issue:
10(1)
Published: Nov. 1, 2020
Abstract
Cancer
immunotherapy
is
a
cutting‐edge
strategy
that
eliminates
cancer
cells
by
amplifying
the
host's
immune
system.
However,
low
response
rate
and
risks
of
inducing
systemic
toxicity
have
raised
uncertainty
in
treatment.
Magnetic
nanoparticles
(MNPs)
as
versatile
theranostic
tool
can
be
used
to
target
delivery
multiple
immunotherapeutics
monitor
cell/tissue
responses.
These
capabilities
enable
real‐time
characterization
factors
contribute
immunoactivity
so
future
treatments
optimized.
The
magnetic
properties
MNPs
further
allow
implementation
navigation
hyperthermia
for
boosting
efficacy
immunotherapy.
multimodal
approach
opens
an
avenue
induce
robust
responses,
minimize
safety
issues,
activities
simultaneously.
Thus,
object
this
review
provide
overview
burgeoning
fields
highlight
novel
technologies
next‐generation
correlates
with
latest
treatment
strategies
explore
crosstalk
between
nanomaterials
This
comprehensive
MNP‐derived
covers
obstacles
opportunities
development
clinical
translation.